Any current/future new fundraising through debt or equity?

The company currently has fully utilized bank loans and peak cash flow due to investments in inventory, receivables, and operating expenses. There is no explicit mention of any ongoing or immediate plans for new fundraising through debt or equity. CAPEX plans were put on hold due to industry challenges but are expected to be renewed in 2-3 months once cash flow eases. The management is focused on easing cash flow in the next 3 months and then deciding on fresh CAPEX plans for the following year. Discussions with credit rating agencies are ongoing regarding revenue and margin improvement, but n

Any current/future capex/capital investment/strategic investment?

Earlier plan for Rs. 200 crores CAPEX over 2 years was put on hold due to a difficult industry environment in the last six months (Page 6). CAPEX will be renewed in the next 2-3 months once cash flow improves (Page 6). Company expects cash flow to ease out drastically in the next 3 months to enable fresh CAPEX plans for the upcoming year (Page 6). Focus on investments made recently includes strengthening dealer network, employee strength (120+ on-roll employees, 1500+ off-roll field assistants), and field staff (Page 21-22). Best Agrolife is investing in international expansion: patent filings

Future growth expectations in sales/revenue/volumes?

Best Agrolife expects a 20% revenue growth for FY25, with confidence in achieving this growth in the first quarter itself. Focus on expanding the B2C segment, which contributed to 60% of total revenue recently. Increased dealer network to over 10,000 dealers and hired more than 120 employees along with 1,500 field assistants for better market penetration. Launching new patented and specialty products such as Orisulam, Defender, and Topramezone to drive sales. Sudarshan acquisition expected to substantially increase turnover from Rs. 30 crores to around Rs. 250 crores, boosting revenue. Long-te

Future growth expectations in earnings/operating earnings/profits/EPS?

The company aims for around 20% revenue growth in FY25, with positive early trends in the first quarter. EBITDA margin guidance for FY25 is targeted at approximately 20%, expecting improvement from ongoing investments. Growth driven primarily by expansion in branded and patented product segments, moving away from bulk/institutional sales. Significant investments made in increasing dealer and employee strength to capture B2C market share. New specialty and patented products are expected to support sustainable growth and margin improvement. Despite past misses in meeting projections due to indus

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention a specific current or expected order book or pending orders value. However, the management discussed ongoing investments in dealer network expansion, employee strength, and field staff, indicating an expectation of future business growth. They emphasized confidence in a good upcoming agricultural season based on Indian Meteorological Department's rainfall prediction of 106% of the long-term average, which suggests increased demand. The company expects that the favorable season will help clear existing inventory and improve financial performance. Growt

Best Agrolife LtdQ4 FY24Fertilizers & Agrochemicals

Best Agrolife Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹14.7P/E: 17.6Market Cap: ₹522 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Best Agrolife expects a 20% revenue growth for FY25, with confidence in achieving this growth in the first quarter itself.
Focus on expanding the B2C segment, which contributed to 60% of total revenue recently.
Increased dealer network to over 10,000 dealers and hired more than 120 employees along with 1,500 field assistants for better market penetration.
Launching new patented and specialty products such as Orisulam, Defender, and Topramezone to drive sales.
Sudarshan acquisition expected to substantially increase turnover from Rs. 30 crores to around Rs. 250 crores, boosting revenue.
Long-term focus on branded business that grew over 100% last year and volume growth of 37% in existing products.
Plans for international expansion by filing patents and setting up subsidiaries abroad to sustain growth.

Margin guidance

Category 3

The company aims for around 20% revenue growth in FY25, with positive early trends in the first quarter.
EBITDA margin guidance for FY25 is targeted at approximately 20%, expecting improvement from ongoing investments.
Growth driven primarily by expansion in branded and patented product segments, moving away from bulk/institutional sales.
Significant investments made in increasing dealer and employee strength to capture B2C market share.
New specialty and patented products are expected to support sustainable growth and margin improvement.
Despite past misses in meeting projections due to industry seasonality and supply chain challenges, management stresses confidence in meeting future guidance.
International market entry and patent filings expected to contribute longer-term earnings growth.
Overall, management is optimistic about improving profitability and operating earnings from FY25 onwards.

See what Best Agrolife Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The company currently has fully utilized bank loans and peak cash flow due to investments in inventory, receivables, and operating expenses.
There is no explicit mention of any ongoing or immediate plans for new fundraising through debt or equity.
CAPEX plans were put on hold due to industry challenges but are expected to be renewed in 2-3 months once cash flow eases.
The management is focused on easing cash flow in the next 3 months and then deciding on fresh CAPEX plans for the following year.
Discussions with credit rating agencies are ongoing regarding revenue and margin improvement, but no concrete update on new debt issuance was provided.
Overall, the company appears to be managing current resources carefully and has not announced any new fundraising through debt or equity at this time.

Order book

The transcript does not explicitly mention a specific current or expected order book or pending orders value.
However, the management discussed ongoing investments in dealer network expansion, employee strength, and field staff, indicating an expectation of future business growth.
They emphasized confidence in a good upcoming agricultural season based on Indian Meteorological Department's rainfall prediction of 106% of the long-term average, which suggests increased demand.
The company expects that the favorable season will help clear existing inventory and improve financial performance.
Growth is anticipated from both the B2C segment (with expanding dealer network of over 10,000 dealers and 1,500 field assistants) and international expansion efforts.
The management remains optimistic about new patented product launches contributing to future order inflows.
Overall, while specific order book numbers are not provided, the company projects growth driven by expanded reach, product launches, and favorable industry conditions.

See what Best Agrolife Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Earlier plan for Rs. 200 crores CAPEX over 2 years was put on hold due to a difficult industry environment in the last six months (Page 6).
CAPEX will be renewed in the next 2-3 months once cash flow improves (Page 6).
Company expects cash flow to ease out drastically in the next 3 months to enable fresh CAPEX plans for the upcoming year (Page 6).
Focus on investments made recently includes strengthening dealer network, employee strength (120+ on-roll employees, 1500+ off-roll field assistants), and field staff (Page 21-22).
Best Agrolife is investing in international expansion: patent filings (10 patents in 54 countries), registrations in multiple geographies (Far East, Africa, Europe), and setting up holding and subsidiaries (Page 5).
Emphasis on CAPEX linked to production facilities to capitalize on backward integration and new patented molecules pipeline (Page 14-15).

Track Best Agrolife Ltd — get its next earnings analysis in your feed

How does Best Agrolife Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisBest Agrolife Ltd

Rev 2Mar 3

See where Best Agrolife Ltd sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Best Agrolife Ltd rank in Fertilizers & Agrochemicals?

Compare Best Agrolife Ltd against every Fertilizers & Agrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Best Agrolife Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Dhanuka Agritech Ltd (Q2 FY27)
657.51 Crores . Key investor presentation takeaways from Dhanuka Agritech Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
Sharda Cropchem Ltd (Q2 FY27)
1,051.7 Cr, up 13% YoY (Q2 FY26: Rs. Key investor presentation takeaways from Sharda Cropchem Ltd's Q2 FY27 investor presentation — and how it ranks against sec
Paradeep Phosphates Ltd (Q2 FY27)
Revenue from operations for the quarter ended 30 September 2026: Rs 7,164.06 crores . Key results statement takeaways from Paradeep Phosphates Ltd's Q2 FY27 ear
Astec Lifescienc (Q2 FY27)
2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.

Compare:vs Coromandel Inter vs UPL Ltd vs F A C T

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →